2002
MADIT II-Based Indication Provides Lifesaving Technology to Thousands of At-Risk Heart Attack Survivors Indianapolis, IN and St. Paul, MN - Guidant Corporation (NYSE and PCX: GDT), a world leader...
Quarterly Sales reach $807 million (+23 percent) with adjusted Net Income of $163 million (+42 percent) and Earnings Per Share of $0.53 (+41 percent) Double-digit sales and earnings growth...
New Solution Offers Fast, Effective Treatment For Common Complication After Cardiac Surgery Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in...
Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease, will conduct a live webcast of its second quarter 2002 earnings...
Study Intended to Expand Indications for VASOVIEW Endoscopic Vessel Harvesting System Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the...
Live Webcast Available Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that it will participate in the...
Relationship Advances Efforts to Increase Patient Awareness of Disease and Therapies Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and...
Guidant Comments on Summary Judgment Ruling in Cook-Boston Scientific Litigation Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT) reported today that the United States District Court...
Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that it will participate in the 23rd Annual Goldman...
Six Month Follow-Up Study Shows 17.5 Percent Binary Restenosis Rate Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac...
New Option Allows Early Intervention of Common Complication Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and...
New Platform Offers Advanced Therapy, Comprehensive Patient Management and Ease-of-Use Features Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE and PCX: GDT), a world leader in...
Inventors of the Implantable Defibrillator Honored by the National Inventors Hall of Fame Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the...
DELIVER and ELUTES Data Continue to Support Benefit of Paclitaxel Eluting Stents Indianapolis, Ind. and Paris - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac...
Company to Hold Mid-Quarter Call Today Indianapolis, Ind. and Menlo Park, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease, today...
Indianapolis, Ind. and Paris - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that the first patient has been treated in...
Live Webcast Available Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that it will host an investor...
Sixth-Generation Stent System Features Enhanced Deliverability, Market-Leading Stent Design Indianapolis, Ind. and Brussels - Guidant Corporation (NYSE and PCX: GDT), a world leader in the...
Live Webcast Available Indianapolis, Ind. - As previously announced, Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease, will host a...
Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease, today announced the launch of its fifth...
Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation today announced that Thomas J. Linnemeier, M.D., FACC, senior vice president, new ventures and chief medical officer, Vascular...
Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that the company has launched the HI-TORQUE BALANCE...
Largest Study to Date, DELIVER II Will Evaluate Clinical Benefit of ACHIEVE Stent in High-Risk Patients Indianapolis, Ind. and Brussels - Guidant Corporation (NYSE and PCX: GDT), a world leader in...
Only Approved Technology to Treat Both Sudden Cardiac Death and Heart Failure; Guidant to Hold Webcast Conference Call Today Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE and...
Guidant to Participate in the Deutsche Bank Securities 27th Annual Healthcare Conference
Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that it will participate in the Deutsche Bank...
New York, NY, and Santa Clara, CA - Clinsights Inc. today announced the launch of the Drug Eluting Stent Center (DESC) on TCTMD - the premier online community for interventional cardiologists and...
Guidant Awarded $158 Million In Damages Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease, reported that an arbitration...
13 Percent Earnings Growth Leads to Earnings Per Share of $0.47, as Adjusted; Second Quarter Financial Guidance Reflects Enhanced Growth Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT),...
International Symposium Covers Latest Techniques and Technologies for Treating Coronary and Peripheral Vascular Disease Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and...
Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that it will participate in the SunTrust Robinson...
Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease, will conduct a live webcast of its first quarter 2002 earnings...
Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that Ginger L. Graham has elected to move from her...
New position will have responsibility for Investor Relations, Corporate Communications, Corporate Marketing and Public Policy Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT), a world...
Agreement with Novartis Pharma AG Broadens Guidant's Drug Eluting Stent Program Company to Host Webcast/Conference Call Today Indianapolis - Novartis Pharma AG and Guidant Corporation announced...
Guidant Announces FDA Approval of INSIGNIA Advanced Pacemaker and Comments on Heart Failure Therapy Filing Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT), a world leader in the...
Physicians Simulate New Interventional Procedure in a Virtual Environment Indianapolis, Ind. and Brussels, Belgium - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of...
Additional Stent Lengths, Improved Materials and Design Give Physicians More Options and Control Indianapolis, Ind. and Menlo Park, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader...
Company Creates Dedicated Peripheral Vascular Sales Organization Indianapolis, IN and Menlo Park, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of...
Live Webcast Available Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiovascular and vascular disease, announced today that it will host an...
Wireless Telecommunication will Enable Internet Monitoring of Patients Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiovascular and vascular...
New Stabilizer Systems Designed to Make Procedure Available to More Patients Brussels, Belgium and Mainz, Germany - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of...
Company to Host Webcast/Conference Call Today Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT), a global leader in cardiac and vascular technology, today reported preliminary results of...
Clinical Trial Fully Enrolled In Less Than Four Months Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT), a global leader in cardiac and vascular technology, today announced that it has...
Innovative Lead Instrumental in Delivering Therapy for Heart Failure Patients Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiovascular and...
Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a global leader in cardiac and vascular technology, today issued the following statement on the status of its international ACTION...
New Stabilizer Systems Designed to Make Procedure Available to More Patients Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment...
Will Provide Physicians with a Cost-Effective, Non-Invasive Means to Monitor Aneurysm Pressure Indianapolis, Ind., Menlo Park, Calif., and Caesaria, Israel - Guidant Corporation (NYSE and PCX:...
Designed for Ease of Handling Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiovascular and vascular disease, announces...
Presentation Accessible Via Webcast Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT), a global leader in cardiac and vascular technology, today announced that Ronald W. Dollens,...
ACHIEVE CE Mark Filing Represents Milestone in Guidant's Drug Eluting Stent Efforts Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT) today announced that the company has filed for CE...